Amneal Pharmaceuticals of New York, LLC 2024-02-28 Health serious FDA
Health · FDA · Recall #FDA-D-0327-2024
Oseltamivir Phosphate for Oral Suspension 6mg/ml, 60 mL (reconstituted) bottle, RX only,… Recall
Issued February 28, 2024 · Amneal Pharmaceuticals of New York, LLC
In February 2024, Amneal Pharmaceuticals of New York, LLC recalled the Oseltamivir Phosphate for Oral Suspension 6mg/ml, 60 mL (reconstituted) bottle, RX only,…, a serious health recall reported by the FDA.
Compiled by Maya Ellison, RecallCheckr
What this means for you
Failed Impurities/Degradation Specifications: Out-of-specification test results.
What you should do
- 1 Stop using Oseltamivir Phosphate for Oral Suspension 6mg/ml, 60 mL (reconstituted) bottle, RX only,… right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact Amneal Pharmaceuticals of New York, LLC to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- Amneal Pharmaceuticals of New York, LLC
- Category
- Health
- Recall date
- February 28, 2024
- Units affected
- Not reported
- Sold at
- Nationwide in the USA
- Recall number
- FDA-D-0327-2024
- Made in
- United States
- Issuing agency
- FDA
In context
- Amneal Pharmaceuticals of New York, LLC has 4 recalls in our database.
- We're tracking 3,576 Health recalls in our database.
- This is the 737th Health recall we've logged in 2024.